About us
About the Access Campaign

Our 2022 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

About us
About the Access Campaign

Our 2022 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

Video |

03 December 2018

Treating kala azar-HIV co-infection in Bihar, India

HIV/AIDS TROPICAL & NEGLECTED DISEASES

India

Read, watch, share

Yusufa Adam, 5 years, received treatment for noma in the Sokoto hospital.

Photograph by Ghada Safaan

Press release |

26 January 2023

Tropical & neglected diseases

MSF calls for increased global investment ahead of World NTD Day

6 min

Photograph by Severine Blanchet

Press release |

23 June 2022

Tropical & neglected diseases

Rwanda

MSF warns that reduced funding for Neglected Tropical Diseases could be devastating

3 min

Issue brief cover image

Issue brief

Issue brief |

16 December 2021

COVID-19 HIV/AIDS Tropical & neglected diseases

Liposomal amphotericin B: Solving the access puzzle

A Médecins Sans Frontières nurse prepares a single dose of LAmB, an intravenous infusion administered over a short period of 2–3 hours.

Photo by Matthew Smeal

Opinion article

Opinion article |

20 August 2021

Tropical & neglected diseases

BMJ Global Health: Control of visceral leishmaniasis in East Africa: fragile progress, new threats

3 min

27 January 2021

Tropical & neglected diseases

Overcoming Neglect

Nursing kala azar-HIV co-infected patients in Patna, Bihar

Video |

03 December 2018

HIV/AIDS Tropical & neglected diseases

India

Nursing kala azar-HIV co-infected patients in Patna, Bihar

Kala azar-HIV co-infection in Bihar

Video |

30 November 2018

Tropical & neglected diseases

India

Explainer: Kala azar-HIV co-infection in Bihar, India

Zoya, who has been treated for kala azar-HIV co-infection and tuberculosis at MSF's ward in Patna, Bihar is one of the many patients navigating the social stigma that is associated with the diseases in the social context of Bihar.

Photograph by Vaishnavi Singh

Feature story |

24 September 2018

Tropical & neglected diseases

HIV-kala azar co-infection stories

10 min